Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLCHICINE-PROTECT
NCT05739929Phase 3Unknown
- Sponsor
- Helwan University
- Start
- Mar 2023
- Primary completion
- Aug 2024
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in coronary artery disease (CAD), sponsored by Helwan University. Status: unknown.
02
Drugs
colchicine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT05739929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05739929.